Patients with acute myocardial infarction (AMI) showing a QT dispersion (QTd) greater than 42 ms face a higher risk of ventricular arrhythmias and in-hospital mortality, according to a prospective study published by Cureus. In a group of 100 patients, 88% exhibited abnormal QT dispersion, with those experiencing ventricular arrhythmias showing a significantly higher mean QTd of 94.9 ms compared to 70.4 ms in those without such arrhythmias.
QT Dispersion Levels Predict Ventricular Arrhythmias
QT dispersion measures the difference between the maximum and minimum QT intervals across a standard 12-lead electrocardiogram (ECG). This measurement reflects the heterogeneity of ventricular repolarization. When this repolarization is inconsistent across the heart’s ventricles, it can create an electrophysiological substrate for re-entry, which triggers ventricular arrhythmias.
The study conducted at the Pacific Institute of Medical Sciences in Udaipur, Rajasthan, found that 30% of the 100 enrolled patients developed ventricular arrhythmias. The data showed a stark contrast in electrical stability: patients with arrhythmias had a mean QTd of 94.9 ± 17.5 ms, while those who remained stable had a mean of 70.4 ± 9.82 ms.
Clinical Outcomes and In-Hospital Mortality
The research indicates that increased QTd is frequently observed in patients suffering from AMI and correlates with poorer in-hospital outcomes. Because a 12-lead ECG is a routine tool in emergency departments and cardiac wards, calculating QTd provides a readily available method to identify patients at higher risk for sudden cardiac death.
While the association between high QTd and mortality is significant, the study authors note that these findings represent associations rather than evidence of independent prognostic prediction or direct causality. The researchers emphasized that current results should be viewed as a signal for further investigation rather than a definitive diagnostic tool.
Comparison of QTd Findings in AMI Patients
| Patient Group | Mean QT Dispersion (QTd) | Clinical Status |
|---|---|---|
| Patients with Ventricular Arrhythmias | 94.9 ± 17.5 ms | High Risk / Unstable |
| Patients without Ventricular Arrhythmias | 70.4 ± 9.82 ms | Lower Risk / Stable |
| Abnormal Threshold | >42 ms | 88% of Study Population |
Requirements for Future Cardiac Research
The study identifies several variables that may influence QTd measurements, including the timing of the ECG assessment, the specific methods used to measure the QT interval, and the reperfusion strategies employed during treatment. Because these factors can vary across different clinical settings, the results may not be consistent across all patient populations.
To determine if QTd can serve as an independent prognostic marker, researchers state that larger multicenter studies are necessary. These future trials must utilize standardized ECG assessments and adjust for potential confounders to isolate the impact of QT dispersion on patient survival.
Common Questions About QT Dispersion in Heart Attacks
How is QT dispersion different from a prolonged QT interval?
A prolonged QT interval measures the total time for ventricular depolarization and repolarization in a single lead. QT dispersion specifically measures the difference between the longest and shortest QT intervals across all 12 leads, highlighting unevenness in the heart’s electrical recovery.
Can a standard ECG detect QT dispersion?
Yes, QTd is calculated using a routine 12-lead ECG by subtracting the minimum QT interval from the maximum QT interval found across the different leads. It does not require specialized equipment beyond the standard ECG machine used in most hospitals.
Does a high QTd value guarantee a ventricular arrhythmia?
In this study, while 88% of patients had an abnormal QTd (>42 ms), only 30% actually developed ventricular arrhythmias, meaning many patients with high dispersion do not experience these specific complications.
Worth a look